SCHEMBL280174

SCHEMBL280174

Cc1nc(C(=O)c2cccs2)sc1CCON(O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.42
TP53 P04637 2/20 0.42
LMNA P02545 1/20 0.42
THRB P10828 1/20 0.42
RAB9A P51151 4/20 0.37
NPC1 O15118 3/20 0.37
HPGD P15428 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ADORA1 P30542 5/20 0.37
ADORA2A P29274 4/20 0.37
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 2/20 0.36
TSHR P16473 1/20 0.36
PSMD14 O00487 1/20 0.36
MMP2 P08253 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX5 P09917 1/20 0.35
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
HPGDS O60760 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL264078 0.82 PTGS2 (0.50) MAPTTP53LMNATHRBRAB9A
SCHEMBL279138 0.76 KDM4E (0.49) MAPTTP53LMNATHRBRAB9A
SCHEMBL279867 0.74 ALDH1A1 (0.37) MAPTTP53LMNATHRBHPGD
SCHEMBL10206331 0.74 ALDH1A1 (0.36) MAPTLMNARAB9ANPC1HPGD
SCHEMBL280316 0.72 HRH2 (0.39) MAPTTP53LMNATHRBHPGD
SCHEMBL280301 0.71 TP53 (0.44) MAPTTP53LMNATHRBALDH1A1
SCHEMBL13763088 0.69 CYP1A2 (0.34) MAPTTP53LMNATHRB
SCHEMBL278857 0.69 LMNA (0.48) MAPTTP53LMNATHRBSMN1; SMN2
SCHEMBL279457 0.68 TRPM8 (0.44) MAPTTP53LMNATHRBSMN1; SMN2
SCHEMBL280047 0.68 FFAR1 (0.46) MAPTTP53LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134010-B2 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease RENOPHARM LTD. (IL) 2012-03-13 US disclosed
US-7968575-B2 Nitric oxide donors and uses thereof RENOPHARM LTD. (IL) 2011-06-28 US disclosed
US-7579477-B2 Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof RENOPHARM LTD. (IL) 2009-08-25 US disclosed
US-7498445-B2 Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof RENOPHARM LTD. (IL) 2009-03-03 US disclosed
US-7368577-B2 Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof RENOPHARM LTD. (IL) 2008-05-06 US disclosed
US-7332513-B2 Thiazole-based nitric oxide donors having acyl substituent(s) and uses thereof RENOPHARM LTD. (IL) 2008-02-19 US disclosed